相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Copper and copper nanoparticles toxicity and their impact on basic functions in the body
M. Pohanka
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2019)
Copper signaling in the brain and beyond
Cheri M. Ackerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A low blood copper concentration is a co-morbidity burden factor in Parkinson's disease development
Ekaterina Y. Ilyechova et al.
NEUROSCIENCE RESEARCH (2018)
Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
Amin Karimi-Moghadam et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Metals and Parkinson's Disease: Mechanisms and Biochemical Processes
Geir Bjorklund et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Iron as a therapeutic target for Parkinson's disease
Caroline Moreau et al.
MOVEMENT DISORDERS (2018)
Association of metals with the risk and clinical characteristics of Parkinson's disease
Mi-Jung Kim et al.
PARKINSONISM & RELATED DISORDERS (2018)
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson's Disease
Federica De Lazzari et al.
AGING AND DISEASE (2018)
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies
Daphne Schneider Cukierman et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases
M. Kawahara et al.
METALLOMICS (2017)
Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster
Juan A. Navarro et al.
FRONTIERS IN GENETICS (2017)
CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord
James B. Hilton et al.
SCIENTIFIC REPORTS (2017)
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease
Antonio Martin-Bastida et al.
SCIENTIFIC REPORTS (2017)
Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain
Benjamin G. Trist et al.
ACTA NEUROPATHOLOGICA (2017)
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
Emma Deas et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation
Rebecca J. Mason et al.
BIOCHEMISTRY (2016)
Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics
Katherine M. Davies et al.
CLINICAL SCIENCE (2016)
Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View
Roberta Filograna et al.
CURRENT NEUROPHARMACOLOGY (2016)
Coordination and redox properties of copper interaction with α-synuclein
Daniela Valensin et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Alpha-synuclein: relating metals to structure, function and inhibition
J. S. McDowall et al.
METALLOMICS (2016)
Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD
Jared R. Williams et al.
NEUROBIOLOGY OF DISEASE (2016)
Reduced net charge and heterogeneity of pI isoforms in familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase
Stephane Roudeau et al.
ELECTROPHORESIS (2015)
Copper Binding to the N-Terminally Acetylated, Naturally Occurring Form of Alpha-Synuclein Induces Local Helical Folding
Marco C. Miotto et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Wilson's disease and other neurological copper disorders
Oliver Bandmann et al.
LANCET NEUROLOGY (2015)
Copper at synapse: Release, binding and modulation of neurotransmission
Nadia D'Ambrosi et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Presynaptic Effects of Levodopa and Their Possible Role in Dyskinesia
Eugene V. Mosharov et al.
MOVEMENT DISORDERS (2015)
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Marco Bisaglia et al.
AGEING RESEARCH REVIEWS (2014)
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid- and Micelle-bound α-Synuclein and Increases Its Affinity for Physiological Membranes
Igor Dikiy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: Mechanism and kinetics
A. Ninh Pham et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Blaine R. Roberts et al.
JOURNAL OF NEUROSCIENCE (2014)
Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry
Nikolaus Krebs et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2014)
Copper pathology in vulnerable brain regions in Parkinson's disease
Katherine M. Davies et al.
NEUROBIOLOGY OF AGING (2014)
Metabolism and functions of copper in brain
Ivo F. Scheiber et al.
PROGRESS IN NEUROBIOLOGY (2014)
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Scott Ayton et al.
ANNALS OF NEUROLOGY (2013)
Copper chaperones. The concept of conformational control in the metabolism of copper
Peep Palumaa
FEBS LETTERS (2013)
Copper(I)-α-Synuclein Interaction: Structural Description of Two Independent and Competing Metal Binding Sites
Francesca Camponeschi et al.
INORGANIC CHEMISTRY (2013)
Brain metal accumulation in Wilson's disease
T. Litwin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Localization of copper and copper transporters in the human brain
Katherine M. Davies et al.
METALLOMICS (2013)
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Alexander S. Maltsev et al.
BIOCHEMISTRY (2012)
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease
Lin W. Hung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Radio labeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybnds carrying MELAS mitochondnal DNA mutation
Yukie Yoshii et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer
Lijuan Kang et al.
PROTEIN SCIENCE (2012)
Coordination Features and Affinity of the Cu2+ Site in the α-Synuclein Protein of Parkinson's Disease
Christopher G. Dudzik et al.
BIOCHEMISTRY (2011)
Bioelements and mineral matter in human livers from the highly industrialized region of the Upper Silesia Coal Basin (Poland)
Lucyna Lewinska-Preis et al.
ENVIRONMENTAL GEOCHEMISTRY AND HEALTH (2011)
Exploring the Structural Details of Cu(I) Binding to α-Synuclein by NMR Spectroscopy
Andres Binolfi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
ATP7A-related copper transport diseases-emerging concepts and future trends
Stephen G. Kaler
NATURE REVIEWS NEUROLOGY (2011)
Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases
Leonid Breydo et al.
METALLOMICS (2011)
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET
Masamichi Ikawa et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Calcium-dependent copper redistributions in neuronal cells revealed by a fluorescent copper sensor and X-ray fluorescence microscopy
Sheel C. Dodani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Menkes disease
Zeynep Tumer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Structural Characterization of a High Affinity Mononuclear Site in the Copper(II)-α-Synuclein Complex
Marco Bortolus et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Metalloproteomics and metal toxicology of alpha-synuclein
Aaron Santner et al.
METALLOMICS (2010)
Metabolic crossroads of iron and copper
James F. Collins et al.
NUTRITION REVIEWS (2010)
Structural insights on physiological functions and pathological effects of α-synuclein
Marco Bisaglia et al.
FASEB JOURNAL (2009)
Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions
M. E. Letelier et al.
JOURNAL OF APPLIED TOXICOLOGY (2009)
Interaction Between α-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson's Disease
Marco Bisaglia et al.
NEUROMOLECULAR MEDICINE (2009)
Thermodynamics imprinting reveals differential binding of metals to α-synuclein:: Relevance to parkinson's disease
Bharathi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice
M. B. H. Youdim et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia
Amy L. Vavere et al.
DALTON TRANSACTIONS (2007)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Interaction of α-synuclein with divalent metal ions reveals key differences:: A link between structure, binding specificity and fibrillation enhancement
Andres Binolfi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
NMR mapping of copper binding sites in alpha-synuclein
YH Sung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Structural characterization of copper(II) binding to α-synuclein:: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
